Ajeet Gordhan, MD
Neuroradiology · Normal, ILNPI 1306892369
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,453 of the $5,716 with a category attached, or 77.9%. 8 manufacturers reported payments, led by Penumbra, Inc. at 36.2% of the total. Reporting peaked in 2019 at $2,568 and has fallen 75.9% since, to $619 in 2025.
Across 41 payments — averaging $139.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Microvention, Inc.$2K
- Stryker$1K
- Medtronic$371
- Philips North America LLC$120
- Edwards Lifesciences$42
- plus $30 from 2 others
What the payments were for
- Travel & lodging$4,45378%
- Food & beverage$1,26422%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 6 | $2,070 |
| Microvention, Inc. | 11 | $1,922 |
| Stryker | 16 | $1,161 |
| Medtronic | 3 | $371 |
| Philips North America LLC | 1 | $120 |
| Edwards Lifesciences | 2 | $42 |
| Cordis US CORP. | 1 | $15 |
| Cardiva Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$1,874
- WEB Aneurysm Embolization System$1,475
- REAL System$1,226
- STENT$1,006
- EVOLVE$750
- WEB$351
- Pipeline$282
- Azurion 7 B20$120
- Penumbra SMART Coil$105
How this compares
$5,716 in reported general payments places this provider in the 85th percentile of 36 neuroradiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 23 | $18,574 |
| EliquisApixaban | 15 | $13,953 |
| ClopidogrelClopidogrel Bisulfate | 72 | $1,127 |
| Levothyroxine Sodium | 11 | $42 |
| Losartan Potassium | 11 | $24 |
Paid to pharmacies, not to this prescriber.
Other neuroradiology in Normal
- Benjamin LiuChicago$23K
- Matthew KuhnSpringfield$21K
- Ramez AbdallaChicago$10K
- Donald CantrellChicago$8K
- Adam WallaceRockford$5K
- Prashant ChawlaChicago$5K
- Woody HanPeoria$4K
- Anthony KamMaywood$3K
- Okan InceChicago$3K
- Mehmet KocakChicago$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.